Softwr

Research · head to head

Greenphire vs LabWare

Greenphire logo

Greenphire

Research

Clinical trial participant payments, reimbursement and travel, now part of Suvoda

From
On request
Rated
-
LabWare logo

LabWare

Research

Enterprise laboratory information management system for regulated labs

From
On request
Rated
-

The short version

  • Each has a real cost: Greenphire the standalone greenphire.com site now redirects to Suvoda and the brands have been integrated, so buyers are contracting with a randomisation and supply vendor and should expect cross selling rather than an independent payments specialist.; LabWare implementation and validation take a year or more, and the services cost frequently exceeds the licence
  • They diverge on capability: Greenphire covers ClinCard, LabWare covers Sample management.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Greenphire and LabWare actually diverge.

Attributes where Greenphire and LabWare differ
AttributeGreenphireLabWare
PlatformsWeb, iOS, AndroidWindows, Web, Cloud, On-premise

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Greenphire

  • ClinCard
  • Direct to bank payment
  • Expense reimbursement
  • Travel and logistics
  • Site payments
  • Budgeting and benchmarking
  • Tax handling

Only in LabWare

  • Sample management
  • Instrument integration
  • Regulatory compliance
  • Stability studies
  • ELN
  • Configuration framework

What people use each for

The jobs each tool is most often brought in to do.

Greenphire

  • A global Phase III trial paying stipends across many countries where participants cannot practically be reimbursed by sponsor accounts payablenot LabWare
  • A decentralised or hybrid trial where participants travel long distances and the sponsor funds flights and accommodationnot LabWare
  • A trial in a population where slow reimbursement drives dropout and same day payment materially helps retentionnot LabWare
  • A sponsor that wants site payment milestones and participant payments handled by one vendor rather than twonot LabWare

LabWare

  • Pharmaceutical quality control laboratories subject to regulatory inspectionnot Greenphire
  • Multi-site laboratory networks needing one method and specification librarynot Greenphire
  • Contract laboratories managing chain of custody across many clientsnot Greenphire
  • Laboratories replacing a validated legacy LIMS they can no longer maintainnot Greenphire

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Greenphire

  • The standalone greenphire.com site now redirects to Suvoda and the brands have been integrated, so buyers are contracting with a randomisation and supply vendor and should expect cross selling rather than an independent payments specialist.
  • Nothing is published on price, and the typical shape of a platform fee plus per participant and per transaction charges means the cost of a trial is not knowable until enrolment is known.
  • Payment method availability varies sharply by country, so a global protocol may end up with card payments in some regions and slow manual processes in others, which undermines the retention argument that justified the purchase.
  • Sites bear the administrative work of enrolling participants and triggering payments but are not the buyer, so adoption depends on the sponsor mandating it and site resistance is a real implementation risk.
  • Participant payments create tax reporting obligations that differ per jurisdiction, and the tooling helps but does not remove sponsor liability, so legal and finance review is required in every country the trial runs in.

LabWare

  • Implementation and validation take a year or more, and the services cost frequently exceeds the licence
  • Pricing is entirely quote-based with no public reference point, even by enterprise standards
  • Extensive configuration means the finished system depends heavily on implementation quality, and outcomes vary widely between customers
  • The interface is functional rather than modern, which is a common objection from scientists used to consumer software
  • Substantially over-specified for research laboratories without regulatory obligations

Pricing, plan by plan

Greenphire

On request
  • Greenphire Patient Payments$undefined/year
    • Priced per study through a sales process
    • Typically a platform fee plus per participant and per transaction charges
    • Funding of the payment float is separate from the software fee

LabWare

On request
  • LabWare LIMS$undefined/year
    • Sample management
    • Instrument integration
    • Regulatory compliance

Which should you pick?

Choose Greenphire if

  • You need clincard.
  • You work on Web, iOS, Android.
  • You also want direct to bank payment.

Choose LabWare if

  • You need sample management.
  • You work on Windows, Web, Cloud, On-premise.
  • You also want instrument integration.

Questions people ask

Is Greenphire or LabWare better?
Neither clearly leads. Greenphire starts at On request and LabWare at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Greenphire or LabWare?
Greenphire starts at On request and LabWare at On request.
Does Greenphire or LabWare run on more platforms?
Greenphire runs on Web, iOS, Android. LabWare runs on Windows, Web, Cloud, On-premise.
What is Greenphire best used for?
Greenphire is most often used for a global phase iii trial paying stipends across many countries where participants cannot practically be reimbursed by sponsor accounts payable, a decentralised or hybrid trial where participants travel long distances and the sponsor funds flights and accommodation, a trial in a population where slow reimbursement drives dropout and same day payment materially helps retention, a sponsor that wants site payment milestones and participant payments handled by one vendor rather than two. Of those, a global phase iii trial paying stipends across many countries where participants cannot practically be reimbursed by sponsor accounts payable and a decentralised or hybrid trial where participants travel long distances and the sponsor funds flights and accommodation are not what LabWare is typically brought in for.
What can Greenphire do that LabWare cannot?
Greenphire covers ClinCard, Direct to bank payment, Expense reimbursement, Travel and logistics. LabWare covers Sample management, Instrument integration, Regulatory compliance, Stability studies.

Answered from the vendors’ own pages

Greenphire: Is Greenphire still sold?

Yes, as Greenphire Patient Payments on the Suvoda platform. The independent website and social presence have been consolidated into Suvoda.

LabWare: Why is LabWare so dominant in pharma?

Validation experience. In a regulated laboratory the software forms part of what an inspector examines, and decades of accumulated validation practice is not something a newer vendor can substitute for.

Greenphire: What is ClinCard?

The reloadable debit card Greenphire issues to participants. Greenphire Patient Payments was formerly known as ClinCard.

LabWare: What does it cost?

Not published. Enterprise licensing plus implementation and validation services, and the services frequently exceed the licence.

Greenphire: Does it publish pricing?

No. Pricing is per study and quoted through sales, and funding the payments themselves is separate from the software fee.

LabWare: How long is implementation?

A year or more for a regulated laboratory, including validation. Anyone quoting substantially less is either scoping narrowly or omitting validation.

Greenphire: Can it pay participants outside the United States?

Yes, in more than thirty currencies, but the available payment method depends on the country.

LabWare: Does it include an electronic laboratory notebook?

Yes, LabWare offers ELN alongside LIMS on the same platform, which avoids the integration problem of running two vendors.

LabWare: Is it suitable for a research lab?

Usually not. Research laboratories without regulatory obligations pay for compliance machinery they do not need, and Benchling or a lighter LIMS fits better.

Share

Related pages

Other head to heads